CD86 and atherosclerosis: Tregs limit the CD80/CD86–CD28-dependent activation of T cells through CTLA-4-dependent downregulation of CD80 and CD86 expression on DCs (Sakaguchi et al., 2020), which may contribute to the reduction in atherosclerosis (Matsumoto et al., 2016).